Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44)

Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44)

Jurisdiction:	Federal
Incentive Type:	Grant Program
Industries:	Medical
Eligible Sector:	Business
Category:	Financial Incentive
Time Period:	FY 2015
Governing Body:	National Institutes of Health
What’s it worth?:	Not mentioned

A Small Business Innovation Technology Transfer Research (STTR) grant opportunity (PA-13-140) for small business concerns (SBCs), with no more than 500 employees, to develop tools that will advance the understanding of the cellular basis of disease.

Maximum funding is generally $150,000 for Phase 1 of the research project and $1,000,000 for Phase 2, with the potential for 50% more (up to $225,000 in Phase 1 and $1,500,000 in Phase 2) or even higher if the additional funding is determined to be justified or necessary.  Full application directions for SG424 (R&R) are available at Grants.gov.